Skip to content

Investigating the effect of using silver nitrate and platelet fibrin glue in the treatment of anal fistulas

The use of silver nitrate and platelet fibrin glue in the treatment of anal fistulas

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191228045924N4
Enrollment
10
Registered
2023-03-25
Start date
2023-04-21
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal fistula. Anal fistula

Interventions

The intervention group includes individuals with perianal fistula resistant to surgical treatment. In the operating room, 2 ml of 10% silver nitrate will first be injected into their perianal fistula

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have a perianal fistula resistant to surgical treatment as diagnosed by a medical specialist Patients should be over 18 years old Obtain written consent

Exclusion criteria

Exclusion criteria: Patients who, in addition to anal fistula, have other urinary fistulas/active infection/carcinoma in situ/tumor.

Design outcomes

Primary

MeasureTime frame
Discharge amount. Timepoint: Before the intervention and after the intervention every 24 hours. Method of measurement: By visual observation of the dressing that is placed on the fistula site.;The duration of recovery, which is the number of days it takes for the discharge from the fistula to stop. Timepoint: Every 24 hours (every day). Method of measurement: By visual observation of the dressing that is placed on the fistula site.;Presence of inflammation and infection. Timepoint: Before the intervention and after the intervention every week for one month. Method of measurement: Clinical examination.

Secondary

MeasureTime frame
Reepithelialisation and fistula closure. Timepoint: During the 6-month follow-up period of the patient. Method of measurement: clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDaryoush Hamidi Alamdari

Mashhad University of Medical Sciences

hamidiad@mums.ac.ir+98 51 3854 3031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026